AC Immune ACIU
NASDAQ ACIU
$2.86 -0.07 (-2.39%)
At close: Sep 4, 2026 · 4:00 PM EDT

AC Immune (ACIU) Interest Coverage Ratio (2015 - 2026)

AC Immune (ACIU) posted quarterly Interest Coverage Ratio of 227.51 for Q1 2026, down 36.58% year-over-year from 358.7 in Q1 2025, and up 434.23% quarter-over-quarter from 42.59 in Q4 2025.

Analysis

AC Immune (ACIU) Interest Coverage Ratio (2015 - 2026) Analysis & Trends

AC Immune (ACIU) has reported Interest Coverage Ratio for 12 consecutive years, with 227.51 the latest figure, recorded in Q1 2026.

  • In Q1 2026, Interest Coverage Ratio fell 36.58% year-over-year to 227.51; the TTM figure through Mar 2026 stood at 129.08 (down 78.02% YoY), while the FY2025 annual figure was 362.92, down 7.85% from the prior year.
  • Interest Coverage Ratio advanced to 227.51 in Q1 2026 per ACIU's latest filing, from 42.59 in the prior quarter.
  • Across five years, Interest Coverage Ratio topped out at 631.33 in Q2 2023 and bottomed at 18697.0 in Q4 2022.
  • Historically, Interest Coverage Ratio has averaged 908.86 across 5 years, with a median of 174.84 in 2022.
  • Annual changes were most pronounced in 2022 — Interest Coverage Ratio slumped 13930.75% — and 2024, when it soared 407.73%.
  • AC Immune's Interest Coverage Ratio stood at 18697.0 in 2022, then jumped by 99.94% to 10.86 in 2023, then tumbled by 5094.11% to 564.18 in 2024, then soared by 107.55% to 42.59 in 2025, then soared by 434.23% to 227.51 in 2026.
  • Business Quant data shows ACIU's Interest Coverage Ratio at 227.51 in Q1 2026, 42.59 in Q4 2025, and 351.43 in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Cover (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 117.59
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -493.00
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -
5 Revolution Medicines 44.33 Bn 44.33 Bn - -21.24
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 8.18
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 2.82
8 Royalty Pharma 28.45 Bn 27.61 Bn - 1.42
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -0.08
10 AC Immune 285.13 Mn 285.13 Mn - -19.56
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -19.56
Mar 31, 2026 227.51
Dec 31, 2025 342.71
Sep 30, 2025 351.43
Jun 30, 2025 387.76
Mar 31, 2025 358.70
Dec 31, 2024 620.60
Sep 30, 2024 -220.27
Jun 30, 2024 616.50
Mar 31, 2024 557.44
Dec 31, 2023 136.19
Sep 30, 2023 594.85
Jun 30, 2023 631.33
Mar 31, 2023 181.14
Dec 31, 2022 -18,697.00
Sep 30, 2022 174.84
Jun 30, 2022 157.61
Mar 31, 2022 122.27
Dec 31, 2021 131.72
Sep 30, 2021 112.06